| Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option? R Mirgayazova, R Khadiullina, V Chasov, R Mingaleeva, R Miftakhova, ... Genes 11 (6), 704, 2020 | 54 | 2020 |
| Key players in the mutant p53 team: small molecules, gene editing, immunotherapy V Chasov, R Mirgayazova, E Zmievskaya, R Khadiullina, A Valiullina, ... Frontiers in Oncology 10, 1460, 2020 | 42 | 2020 |
| Promising new tools for targeting p53 mutant cancers: Humoral and cell-based immunotherapies V Chasov, M Zaripov, R Mirgayazova, R Khadiullina, E Zmievskaya, ... Frontiers in Immunology 12, 707734, 2021 | 35 | 2021 |
| USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective G Korenev, S Yakukhnov, A Druk, A Golovina, V Chasov, R Mirgayazova, ... Cancers 14 (22), 5539, 2022 | 26 | 2022 |
| Novel Isatin-based activator of p53 transcriptional functions in tumor cells R Mirgayazova, R Khadiullina, R Mingaleeva, V Chasov, M Gomzikova, ... Molecular Biology Research Communications 8 (3), 119, 2019 | 25 | 2019 |
| Proximal transcribed regions of bacterial promoters have a non-random distribution of A/T tracts ON Ozoline, VV Chasov, AA Deev, MV Arkhipova, A Travers Nucleic acids research 27 (24), 4768-4774, 1999 | 24 | 1999 |
| Assessment of thermal stability of mutant p53 proteins via differential scanning fluorimetry R Khadiullina, R Mirgayazova, D Davletshin, E Khusainova, V Chasov, ... Life 13 (1), 31, 2022 | 18 | 2022 |
| Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies V Chasov, E Zmievskaya, I Ganeeva, E Gilyazova, D Davletshin, ... Antibodies 13 (1), 10, 2024 | 15 | 2024 |
| RNA–DNA and DNA–DNA base-pairing at the upstream edge of the transcription bubble regulate translocation of RNA polymerase and transcription rate M KIreeva, C Trang, G Matevosyan, J Turek-Herman, V Chasov, ... Nucleic acids research 46 (11), 5764-5775, 2018 | 15 | 2018 |
| N-and C-terminal regions of the small heat shock protein IbpA from Acholeplasma laidlawii competitively govern its oligomerization pattern and chaperone-like activity LS Chernova, MI Bogachev, VV Chasov, IE Vishnyakov, AR Kayumov RSC Advances 10 (14), 8364-8376, 2020 | 13 | 2020 |
| Evaluation of GHK peptide–heparin interactions in multifunctional liposomal covering V Nikolaeva, M Kamalov, TI Abdullin, D Salakhieva, V Chasov, A Rogov, ... Journal of Liposome Research 34 (1), 18-30, 2024 | 6 | 2024 |
| Distribution and functional significance of A/T tracts in promoter sequences of Escherichia coli VV Chasov, AA Deev, IS Masulis, ON Ozoline Molecular biology 36, 537-542, 2002 | 6 | 2002 |
| Some aspects of protein-nucleic acid recognition during transcription initiation IS Masulis, VV Chasov, EG Kostianitsyna, ON Ozolin Molekuliarnaia biologiia 32 (4), 598-602, 1998 | 5 | 1998 |
| Structural and functional analysis of T7D promoter and its complex withE. coli RNA polymerase ON Ozoline, IS Masulis, VV Chasov, NN Demina, SG Kamzolova Russian chemical bulletin 44 (7), 1321-1326, 1995 | 5 | 1995 |
| Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation V Chasov, E Zmievskaya, I Ganeeva, E Gilyazova, D Davletshin, ... Journal of Biomedical Research 38 (6), 531, 2024 | 3 | 2024 |
| Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis V Chasov, I Ganeeva, E Zmievskaya, D Davletshin, E Gilyazova, ... Cells 13 (15), 1282, 2024 | 2 | 2024 |
| Asymmetric T-cell division: Insights from cutting-edge experimental techniques and implications for immunotherapy Y Kaminskiy, I Ganeeva, V Chasov, A Kudriaeva, E Bulatov Frontiers in Immunology 15, 1301378, 2024 | 2 | 2024 |
| Fourier Transform Infrared Spectroscopy Analysis of Human Osteosarcoma Bone Tissue VV Chasov, IS Raginov, SN Medvedeva, I Safin, AA Rizvanov BioNanoScience 8, 481-483, 2018 | 2 | 2018 |
| Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy V Chasov, E Gilyazova, I Ganeeva, E Zmievskaya, D Davletshin, ... Biomolecules 14 (12), 1653, 2024 | 1 | 2024 |
| Anticancer therapeutic strategies for targeting mutant p53-Y220C V Chasov, D Davletshin, E Gilyazova, R Mirgayazova, A Kudriaeva, ... Journal of Biomedical Research 38 (3), 222, 2024 | 1 | 2024 |
